Clinical Impact of Preoperative Albumin-Globulin Ratio in Patients with Rectal Cancer Treated with Preoperative Chemoradiotherapy

0
0 / 5 (0 votos)

Oncology: International Journal of Cancer Research and Treatment

Fecha de publicación: 11 july 2018

DOI: https://doi.org/10.1159/000490149

Autores: Toiyama Y., Oki S., Okugawa Y., Ide S., Yasuda H., Fujikawa H., Yoshiyama S., Hiro J., Ohi M.,  Inoue Y., Araki T., Kusunoki M.

Background: The serum albumin-globulin ratio (AGR) is associated with malignancy outcomes. However, among patients with rectal cancer (RC) who undergo neoadjuvant chemoradiotherapy (nCRT), the clinical and prognostic significance of the pretreatment AGR is unclear.

Seguir leyendo